126 related articles for article (PubMed ID: 18050015)
1. Renal transplant and secondary hyperparathyroidism.
Gøransson LG; Bergrem H
Scand J Urol Nephrol; 2007; 41(6):553-7. PubMed ID: 18050015
[TBL] [Abstract][Full Text] [Related]
2. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.
Boudville NC; Hodsman AB
Nephrol Dial Transplant; 2006 Sep; 21(9):2621-4. PubMed ID: 16644777
[TBL] [Abstract][Full Text] [Related]
3. Secondary hyperparathyroidism after kidney transplantation: a cross-sectional study.
Marcén R; Ponte B; Rodríguez-Mendiola N; Fernández Rodriguez A; Galeano C; Villafruela JJ; Teruel JL; Burgos FJ; Ortuño J
Transplant Proc; 2009; 41(6):2391-3. PubMed ID: 19715929
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function.
Bleskestad IH; Bergrem H; Leivestad T; Hartmann A; Gøransson LG
Clin Transplant; 2014 Apr; 28(4):479-86. PubMed ID: 25649861
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.
Oyama Y; Kazama JJ; Omori K; Higuchi N; Kameda S; Yamamoto S; Ito Y; Maruyama H; Narita I; Gejyo F
Clin Exp Nephrol; 2005 Jun; 9(2):142-7. PubMed ID: 15980949
[TBL] [Abstract][Full Text] [Related]
6. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M
Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
[TBL] [Abstract][Full Text] [Related]
7. Intact parathyroid hormone levels in renal transplant patients with normal transplant function.
Bleskestad IH; Bergrem H; Leivestad T; Gøransson LG
Clin Transplant; 2011; 25(5):E566-70. PubMed ID: 21955131
[TBL] [Abstract][Full Text] [Related]
8. Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23.
Mazzaferro S; Pasquali M; Pugliese F; Citterio F; Gargiulo A; Rotondi S; Tartaglione L; Conte C; Pirrò G; Taggi F
J Nephrol; 2012; 25(6):1108-18. PubMed ID: 22383345
[TBL] [Abstract][Full Text] [Related]
9. Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.
Ambrus C; Molnar MZ; Czira ME; Rosivall L; Kiss I; Remport A; Szathmari M; Mucsi I
Int Urol Nephrol; 2009 Dec; 41(4):1029-38. PubMed ID: 19701690
[TBL] [Abstract][Full Text] [Related]
10. Secondary hyperparathyroidism and risk factors in patients undergoing peritoneal dialysis in a tertiary hospital.
Suwan N
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S101-5. PubMed ID: 22043575
[TBL] [Abstract][Full Text] [Related]
11. Dietary vitamin D intake is not associated with 25-hydroxyvitamin D3 or parathyroid hormone in elderly subjects, whereas the calcium-to-phosphate ratio affects parathyroid hormone.
Jungert A; Neuhäuser-Berthold M
Nutr Res; 2013 Aug; 33(8):661-7. PubMed ID: 23890356
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. Effect of calcium and 1,25 dihydroxyvitamin D on the level of parathyroid hormone in patients with secondary hyperparathyroidism due to chronic renal insufficiency.
Vucković S; Paunković N
Med Pregl; 1993; 46 Suppl 1():40-2. PubMed ID: 8569602
[TBL] [Abstract][Full Text] [Related]
14. Association of calcium, phosphate and parathyroid hormone with renal allograft function: a retrospective cohort study.
Hiemstra TF; Brown AJ; Chaudhry AN; Walsh M
Am J Nephrol; 2013; 37(4):339-45. PubMed ID: 23548209
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial to compare the efficacy and safety of oral paricalcitol with oral calcitriol in dialysis patients with secondary hyperparathyroidism.
Ong LM; Narayanan P; Goh HK; Manocha AB; Ghazali A; Omar M; Mohamad S; Goh BL; Shah S; Seman MR; Vaithilingam I; Ghazalli R; Rahmat K; Shaariah W; Ching CH;
Nephrology (Carlton); 2013 Mar; 18(3):194-200. PubMed ID: 23311404
[TBL] [Abstract][Full Text] [Related]
16. Alphacalcidol oral pulses are effective in secondary hyperparathyroidism prior to dialysis.
Koskimies O; Ala-Houhala M
Clin Nephrol; 1996 Jul; 46(1):70-1. PubMed ID: 8832157
[TBL] [Abstract][Full Text] [Related]
17. Early development of secondary hyperparathyroidism following renal transplantation.
Isaksson E; Sterner G
Nephron Clin Pract; 2012; 121(1-2):c68-72. PubMed ID: 23107897
[TBL] [Abstract][Full Text] [Related]
18. Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study.
Zehnder D; Landray MJ; Wheeler DC; Fraser W; Blackwell L; Nuttall S; Hughes SV; Townend J; Ferro C; Baigent C; Hewison M
Nephron Clin Pract; 2007; 107(3):c109-16. PubMed ID: 17890873
[TBL] [Abstract][Full Text] [Related]
19. Response of a single 'mega intramuscular dose' of vitamin D on serum 25OHD and parathyroid hormone levels.
Khan AH; Rohra DK; Saghir SA; Udani SK; Wood R; Jabbar A
J Coll Physicians Surg Pak; 2012 Apr; 22(4):207-12. PubMed ID: 22482374
[TBL] [Abstract][Full Text] [Related]
20. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
